Corona's third wave is forecast to reach its peak in October-November

If a new variant arrives, the third wave is expected to spread quickly

Scientists say masks and social distance are essential to avoid the third wave

New Delhi: After the second wave of corona calmed down in the country, scientists are now fearing a third wave. Scientists on a government panel linked to Corona's various affairs say a third wave could reach its peak in October-November if precautions and safety are not maintained.

However, these scientists have given a reassuring information that the number of cases in the third wave will be half that of the second wave. I.E.T. Professor Maninder Agarwal of Kanpur has estimated the beginning of the third wave of Corona based on the mathematical model formula.

They conclude that the third wave is expected to see an increase in the number of cases in early October. The transition will then increase very rapidly in November and the number of infected people will gradually decrease after November 15th. This researcher claims that the third wave will not be fatal compared to the second wave.

He says that in the meantime, if a new variant of the corona virus emerges, the third wave could spread very quickly. However he has given reassuring information that the third wave will have half the cases than the second wave. Adherence to rules, including masks and social distance, is required as part of the third wave precaution. It is worth mentioning that Dr. Professor Agarwal made a clear prediction of the second wave.

No antibodies in 16% of samples even after both doses of Covishield: study

Antibodies against the delta variant (B 1.617.2) of the corona virus were not found in 16.1 percent of those receiving both doses of the Covishield vaccine, a new study claims.

It further stated that 58.1 per cent antibodies were not found in samples of people who had taken a single dose of the Covidshield vaccine. The study also found that trites of vaccine-derived antibodies target coronavirus and kill it.

The antibody against the Delta variant was 78 percent lower in those receiving a single dose of the vaccine than in the B1 variant of Titrace corona. Whereas, it was 69 percent lower in both the dose takers. Antibody titrase was found to be 66 percent lower in those taking one dose and 38 percent lower in those taking both doses in people who had been infected.